BRIANA LAFORGE: Open Payments
NPI 1891352902 · PARSONS, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$596 in 38 payments from 6 companies in 2025. Trend: 2023 $484 · 2024 $623 · 2025 $596
Food & beverage: $596
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $238 |
| AstraZeneca Pharmaceuticals LP | 10 | $216 |
| Novo Nordisk Inc | 4 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Lilly USA, LLC | 1 | $14 |
Products named: AIRSUPRA, QULIPTA, VRAYLAR, FARXIGA, UBRELVY, BREZTRI, CAPLYTA, Wegovy.
Industry payments across KS — which companies pay providers there.
